Voltage-gated calcium channel α<sub>2</sub>δ-1 subunit is involved in the regulation of glucose-stimulated GLP-1 secretion in mice
Glucagon-like peptide-1 (GLP-1) is an incretin produced by enteroendocrine preproglucagon (PPG)-expressing cells in response to nutrient ingestion that potentiates insulin secretion. The voltage-gated Ca<sup>2+</sup> channel has been reported previously to be involved in glucose-stimulated GLP-1 secretion; in this study, we show that PPG-cells in upper and lower small intestine substantially express the voltage-gated Ca<sup>2+</sup> channel α<sub>2</sub>δ-1 subunit (Ca<sub>V</sub>α<sub>2</sub>δ-1). In vitro experiments using NCI-H716 cells demonstrate that inhibition of Ca<sub>V</sub>α<sub>2</sub>δ-1 by gabapentin (GBP), an inhibitory ligand of the α<sub>2</sub>δ subunit, attenuates glucose-stimulated intracellular calcium elevation and reduces GLP-1 secretion. In addition, systemic administration of gabapentin significantly reduces glucose-stimulated GLP-1 secretion without affecting blood glucose levels in wild-type mice. Furthermore, knockout mice of intestine-specific <i>Cacna2d1</i>, a gene encoding Ca<sub>V</sub>α<sub>2</sub>δ-1, exhibit reduced GLP-1 secretion in response to oral glucose administration regardless of sex. These results demonstrate that Ca<sub>V</sub>α<sub>2</sub>δ-1 expressed in PPG-cells plays an important role in glucose-stimulated GLP-1 secretion and represents a potential target in the treatment of diabetes and obesity.<b>NEW & NOTEWORTHY</b> In this study, we establish high expression of the voltage-gated Ca<sup>2+</sup> channel α<sub>2</sub>δ-1 subunit (Ca<sub>V</sub>α<sub>2</sub>δ-1) subunit in enteroendocrine glucagon-like peptide-1 (GLP-1) producing cells and elucidate its role in GLP-1 secretion, providing a more detailed understanding of the mechanism of GLP-1 secretion.
Authors
- Naoki Wada (ORCID: https://orcid.org/0000-0003-4271-4039)
- Eri Ikeguchi-Ogura
- Kana Yamamoto (ORCID: https://orcid.org/0000-0002-7136-6849)
- Norio Harada (ORCID: https://orcid.org/0000-0001-8720-1013)
- Yoshitaka Hayashi (ORCID: https://orcid.org/0000-0002-7557-4303)
- Takaaki Murakami (ORCID: https://orcid.org/0000-0003-3844-1138)
- Nobuya Inagaki (ORCID: https://orcid.org/0000-0001-8261-2593)
- Daisuke Yabe (ORCID: https://orcid.org/0000-0002-5334-7687)
- Muhammad Ihsan Fauzi (ORCID: https://orcid.org/0000-0001-9097-3938)
- Yuhan Yang (ORCID: https://orcid.org/0000-0002-4405-5711)
- Shunsuke Yamane
Institutions
- University of Fukui (JP)
- Kyoto University (JP)
- Kitano Hospital (JP)
- Nagoya University (JP)
Publication Details
- Journal
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1152/ajpgi.00279.2024
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Diabetes Foundation
- Japan Science and Technology Agency